← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications and studies (1939)
- Targeting cuproptosis: a potential new therapeutic strategy for idiopathic pulmonary fibrosis. (2026/12/01) ♡
- Evaluating prognostic value of the prognostic nutritional index, CRP-to-albumin ratio and lymphocyte-to-CRP ratio in patients with idiopathic pulmonary fibrosis. (2026/12/01) ♡
- Multi-omics reveals the effects and mechanisms of Xinxue Granules against idiopathic pulmonary fibrosis through activating the cAMP/EPAC/CREB axis. (2026/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting alveolar type II cell dysfunction in idiopathic pulmonary fibrosis: Molecular mechanisms and emerging therapeutic strategies (Review). (2026/09/01) ♡
- Environmental nitro-aromatic compounds link pulmonary fibrosis through BCL2L1 structural destabilization. (2026/09/01) ♡
- TRPA1 Regulates Fibrosis-Associated Transcriptional Pathways in Human Lung Epithelial Cells. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Pathophysiology of pulmonary fibrosis associated with monogenic defects of telomere homeostasis]. (2026/08/10) ♡
- Identification of ZNF331 as a Biomarker for Obstructive Sleep Apnea in Idiopathic Pulmonary Fibrosis Through Integrated Bioinformatics Analysis and Clinical Validation. (2026/08/10) ♡
- IGF2BP3 promotes early angiogenesis in pulmonary fibrosis by stabilizing HIF-1α. (2026/08/07) ♡
- Identification of senescence-related genes in diagnosing idiopathic pulmonary fibrosis via integrating bioinformatics analysis and machine learning. (2026/08/07) ♡
- Comprehensive assessment of complete blood count as a prognostic biomarker in interstitial lung diseases. (2026/08/07) ♡
- Optimal timing, duration and sequencing of therapy for progressive pulmonary fibrosis: the urgent need to move beyond the 'wait-to-fail' paradigm. (2026/08/07) ♡
- Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis. (2026/08/07) ♡
- Pharmacokinetics and Safety of Nerandomilast in Healthy Volunteers. (2026/08/06) ♡
- Human Embryonic Stem Cell-Derived Immunity-And-Matrix-Regulatory Cells Attenuate Pulmonary Fibrosis via MMP1-Mediated Collagen Degradation. (2026/08/05) ♡
- The Gut Speaks to the Lung: Fecal Microbiota and Survival in Idiopathic Pulmonary Fibrosis. (2026/08/05) ♡
- Integrative single‑cell and bulk transcriptomic profiling reveals MMP1 as a core effector and CTSB as a putative collaborator in ATBC‑aggravated pulmonary fibrosis. (2026/08/05) ♡
- Large Language Models for Classifying Usual Interstitial Pneumonia from Radiology Reports: Native Reasoning Versus Structured Prompting. (2026/08/05) ♡
- Numb Mediates IL-1β/TGF-β1-Driven Inflammation-Fibrosis Coupling in Idiopathic Pulmonary Fibrosis. (2026/08/04) ♡
- Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real-world data from the ILD-PRO Registry. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Theranostic innovation in infectious lung diseases: integrating biotechnology and nanotechnology for precision medicine. (2026/08/04) ♡
- Validation of claims-based algorithms for identifying selected interstitial lung disease (idiopathic interstitial pneumonias and drug-induced interstitial lung disease). (2026/08/04) ♡
- BCL9 inhibition promotes fibroblast lipogenesis by regulating macrophage-fibroblast interactions to attenuate pulmonary fibrosis. (2026/08/03) ♡
- Mannose-modified tobacco mosaic virus-mediated macrophage regulation inhibits pulmonary fibrosis progression. (2026/08/03) ♡
- Metabolic Control of Alveolar Epithelial Regeneration: Implications for Lung Repair and Pulmonary Fibrosis. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Distinguishing true from false idiopathic pulmonary fibrosis: Progress in biomarkers for early identification of rheumatoid arthritis. (2026/08/03) ♡
- Single-cell RNA sequencing reveals aberrant airway epithelial-immune cell cross-talk in pulmonary fibrosis. (2026/08/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Barriers to rehabilitation in a Jehovah's Witness post-bilateral lung transplant. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A self-sustaining repair circuit drives the progression of pulmonary fibrosis. (2026/08/01) ♡
- Exposure-informed lung transcriptomic analysis links predicted NNK targets to cell type-specific remodeling programs in idiopathic pulmonary fibrosis. (2026/07/31) ♡
- FABP5 attenuates pulmonary fibrosis by regulating lipid metabolism in type II alveolar epithelial cells. (2026/07/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Troponin in Autoimmune Rheumatic Diseases: Lights and Shadows. (2026/07/31) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study. (2026/07/31) ♡
- LGMN regulates endothelial-to-mesenchymal transition via the p38 MAPK pathway to promote pulmonary fibrosis. (2026/07/30) ♡
- [(18)F]FAPI-42 PET/CT for prognostic assessment in idiopathic pulmonary fibrosis: a prospective head-to-head comparison with [(18)F]FDG PET/CT. (2026/07/30) ♡
- Remotely Monitored Home-based Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: Results of a Randomized Controlled Trial. (2026/07/30) ♡
- Effect of nerandomilast on survival in patients with pulmonary fibrosis. (2026/07/30) ♡
- Telomere dysfunction and mucociliary impairment drive idiopathic pulmonary fibrosis susceptibility: insights from a Sardinian whole-exome study. (2026/07/30) ♡
- Divergent plasma lipidomic signatures characterizing the pathophysiological heterogeneity of COPD and pulmonary fibrosis. (2026/07/29) ♡
- ADAMTS14 is a Novel Modulator of Fibroblast Mechanoactivation in Pulmonary Fibrosis. (2026/07/28) ♡
- Autophagy Induced by Glycosylated CD147 Attenuates Fibroblast Activation and Myofibroblast Differentiation. (2026/07/28) ♡
- Single-Cell Analysis Identifies Factors Associated with Rheumatoid Arthritis-Related Interstitial Lung Disease in Comparison with Idiopathic Pulmonary Fibrosis. (2026/07/28) ♡
- A SNP altering the MUC5AC mucin structure is increased in idiopathic pulmonary fibrosis together with the MUC5B SNP. (2026/07/28) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Molecular plasticity of LAMA3 across the disease spectrum: pathogenic mechanisms and clinical translation. (2026/07/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients. (2026/07/27) ♡
- Pleuroparenchymal fibroelastosis-like findings identify an idiopathic pulmonary fibrosis subgroup with shortened telomeres and poor prognosis. (2026/07/27) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of combination metformin and nintedanib therapy in a mouse model of irradiation-induced pulmonary fibrosis. (2026/07/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progresses on the regulatory roles of microRNAs in radiation-induced pulmonary fibrosis. (2026/07/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cellular senescence and inflammageing: from mechanisms to senotherapeutic interventions. (2026/07/23) ♡
- Causal Association Between Idiopathic Pulmonary Fibrosis and Coronary Artery Disease: A Bidirectional Two-Sample Mendelian Randomization. (2026/07/23) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.